SIGIRR: An Orphan Receptor Mediating Anti-inflammatory Actions
Expert Reviews in Molecular Medicine · 2025 · 27
DOI: 10.1017/erm.2025.10009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, online erschienen am 30.06.2025. Verfasst von Siqi Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, First Hospital of Jilin University, Changchun, Jilin, P.R. China. Hauptthemen laut MEDLINE: Receptors, Interleukin-1, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
SIGIRR, also known as the single immunoglobulin interleukin-1 receptor (IL-1R)-related molecule, is a member of the IL-1 receptor superfamily and is believed to play a pivotal role in inflammation and anti-inflammatory regulation within the body. Studies have shown that SIGIRR expression is associated with autoimmunity, inflammatory disorders, graft rejection, viral infection, thrombosis and tumour progression. Due to its unique structure and function, SIGIRR is commonly referred to as an ‘orphan receptor’, with IL-37 being the only confirmed ligand molecule for SIGIRR to date. The primary mechanism through which SIGIRR exerts its anti-inflammatory regulatory effect involves the negative modulation of the Toll-like receptor-IL-1R (TLR-IL-1R) signalling pathway. TLR-IL-1R signalling plays critical roles in immune responses triggered by microbial invasion and alterations in the tumour immune microenvironment. This article provides an overview of research findings on SIGIRR as an orphan receptor and its regulatory role in maintaining a delicate balance between natural immune activation and uncontrolled inflammatory processes under pathological conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology, First Hospital of Jilin University, Changchun, Jilin, P.R. China.
- Clinical Medical College of Jilin University, Changchun, Jilin, P.R. China.
- National Engineering Laboratory for Druggable Gene and Protein Screening, https://ror.org/02rkvz144Northeast Normal University, Changchun, Jilin, P.R. China.
- The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, NanjingChina.
ORCID-Profile: Ying Shi
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Cheng, S., Cui, L., Chen, J., Xiu, Q., Si, R., Yang, X., & Shi, Y. (2025). SIGIRR: An Orphan Receptor Mediating Anti-inflammatory Actions. Expert Reviews in Molecular Medicine, 27. https://doi.org/10.1017/erm.2025.10009
Vancouver
Cheng S, Cui L, Chen J, Xiu Q, Si R, Yang X, et al. SIGIRR: An Orphan Receptor Mediating Anti-inflammatory Actions. Expert Reviews in Molecular Medicine. 2025;27. doi:10.1017/erm.2025.10009
BibTeX
@article{Cheng2025,
author = {Cheng, Siqi and Cui, Lingyue and Chen, Jingyi and Xiu, Qianwei and Si, Rujia and Yang, Xiaoguang and Shi, Ying},
title = {SIGIRR: An Orphan Receptor Mediating Anti-inflammatory Actions},
journal = {Expert Reviews in Molecular Medicine},
year = {2025},
volume = {27},
doi = {10.1017/erm.2025.10009}
}
EUVIMED